Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1827PDF: 1184HTML: 532 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1624PDF: 1438HTML: 126 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3966PDF: 1416HTML: 2205Fig.1: 318Fig. 2: 302 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2792PDF: 1779HTML: 2478Table1: 322 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1140PDF: 590HTML: 762 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2402PDF: 1756HTML: 754 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3702PDF: 1397HTML: 2429Fi.1 Gritti.Rambaldi: 284 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
6029PDF: 1137HTML: 503TABLE: 252FIGURES: 349 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1562PDF: 896HTML: 1047 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1682PDF: 1055HTML: 279 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6042PDF: 1648HTML: 1690Untitled: 306 -
TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES
151PDF: 80Suppl. Files: 23Html: 40Html Suppl. Files: 42 -
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
205PDF: 76Suppl. Files: 19Html: 45Html Suppl. Files: 13 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
206PDF: 169Suppl. Files: 37Html: 39Html Suppl. Files: 26 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5282PDF: 3058HTML: 2390 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2187PDF: 2059HTML: 816 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2130PDF: 898HTML: 2240Table 1: 255Table 2: 264Table 3: 263Table 4: 256Table 5: 283Tble 6: 250Cover Letter: 276Greene Tab.7: 271 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1532PDF: 675HTML: 4208 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2596PDF: 1319HTML: 3926 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2164PDF: 898HTML: 693 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2765PDF: 1315HTML: 1140 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3281PDF: 1143HTML: 3385 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3433PDF: 1221HTML: 2044 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3649PDF: 1381HTML: 8445 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2906PDF: 1040HTML: 625 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3470PDF: 1155HTML: 2611







